←
Dr. Michael Garshick271 posts
Dr. Michael Garshick avatar

Dr. Michael Garshick

@garshick
◷ Joined July 2017▧ 15 Photos and videos
Glenn Fishman avatar
⟳ Dr. Michael Garshick retweeted
Glenn Fishman@glennfishman·Nov 9

Nice to see a former star @NYULH_DeptofMed Cardiology fellow evolve from trainee himself into the senior author and mentor of a current fellow. The virtuous cycle at its best.

NYU CVD Prevention avatar
⟳ Dr. Michael Garshick retweeted
NYU CVD Prevention@NYUCVDPrevent·Nov 8

NYU Langone Cardiology making its mark at #ScientificSessions26! It’s a wonderful forum to share research, exchange ideas, and connect with colleagues across the field, including Dr. Jennifer Mieres. What an exceptional group representing the cardiology community!🫀

Post attachment
NYU CVD Prevention avatar
⟳ Dr. Michael Garshick retweeted
NYU CVD Prevention@NYUCVDPrevent·Apr 23

Starting tomorrow! 🫀🔥 Follow #CVinflame2026 + Dr. Rafael Toro (@RafaelEToroM), CardioNerds Conference Scholar, for live updates from the 6th Annual North American #CardioRheum Symposium. Still need to register? ⤵️ nyulmc.org/cvinflammationcme @CardioNerds @garshick @Bweber04

Tomorrow is the day! The 6th Annual Cardiometabolic Risk in Inflammatory Conditions Symposium is here. Stay tuned for live highlights and key takeaways! #CVinflame2026 @NYUCVDPrevent @garshick @Bweber04 @CardioNerds

Post attachment
Ron Blankstein avatar
⟳ Dr. Michael Garshick retweeted
Ron Blankstein@RonBlankstein·4 Nov 2025

Excited to share our @JACCJournals #JACCIMG paper led by ⭐️@Bweber04 on AI detection of CAC on chest CT among 2,546 individuals with IMID (SLE/RA/Psoriasis) who did not have hx of ASCVD ~50% had CAC --> most not on statin! ➡️Over 8 yrs, AI CAC provided robust a/w MACE + ACM

Post attachmentPost attachmentPost attachmentPost attachment
NYU CVD Prevention avatar
⟳ Dr. Michael Garshick retweeted
NYU CVD Prevention@NYUCVDPrevent·10 Nov 2025

How do statins enhance endothelial health & reduce #inflammation? Dr. Michael Garshick will present important findings from the Cardiometabolic Health Strategically Focused Research Network. Mon, 11/10, 11:06-11:11 AM Basic Sci Zone Moderated Digital Poster 26: VB.MDP.16

Post attachment
NYU Grossman School of Medicine avatar
⟳ Dr. Michael Garshick retweeted
NYU Grossman School of Medicine@nyugrossman·28 Mar 2025

2/Psoriasis is a skin disease that causes inflammation, and it’s been linked to heart problems. Michael Garshick, MD, director of the Cardio-Rheumatology Program, explores how inflammation in psoriasis may promote plaque buildup in arteries. 📍Sat, 11AM CT | Session 1041

Post attachment
Pablo Corral MD avatar
⟳ Dr. Michael Garshick retweeted
Pablo Corral MD@drpablocorral·12 Dec 2024

👉Two great manuscripts about inflammation and CVD 🔓Open Access 1️⃣Novel Therapeutics and Upcoming Clinical Trials Targeting Inflammation in Cardiovascular Diseases ☝️This review summarizes the main characteristics and findings of completed and upcoming randomized controlled trials directly targeting inflammation in CVDs, and discusses major challenges and future perspectives in the exciting and constantly expanding landscape of cardioimmunology ahajournals.org/doi/full/10.… 2️⃣ Immune-Mediated Inflammatory Diseases, Dyslipidemia, and Cardiovascular Risk: A Complex Interplay ☝️ This review aims to critically evaluate the current understanding of the relationship between immune-mediated inflammatory diseases and dyslipidemia, the underlying mechanisms contributing to atherogenesis, and the impact of various pharmacotherapies on lipid profiles and cardiovascular risk. We also discuss the role of lipid-lowering therapies, particularly statins, in managing residual risk in this high-risk population and explore the potential of emerging therapies with complementary anti-inflammatory and lipid-lowering effects. ahajournals.org/doi/full/10.… @society_eas @atvbahajournals

Post attachmentPost attachmentPost attachment